Radiotherapy Market by Type (External (IGRT, IMRT, 3D-CRT, Stereotactic), Brachytherapy (LDR, HDR)), Product (LINAC, CyberKnife, Gamma Knife, Tomotherapy, Particle Therapy, Cyclotron), Application (Prostate, Breast), End User (Hospital) - Forecasts to 2023
Get in-depth analysis of how COVID-19 is impacting the Radiotherapy Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Radiotherapy Market
Request Now[266 Pages Report] The radiotherapy market is projected to grow from an estimated USD 5.6 billion in 2018 to USD 6.8 billion by 2023, at a CAGR of 4.1% during the forecast period.
MnM helped the client to expand into 6mV single-photon radiotherapy systems market resulting in an incremental revenue of USD 50 million by 2022
Client’s Problem Statement
Our client was keen on understanding the market value of 6mV single-photon radiotherapy systems in developing countries through end-user perception analysis, i.e., knowing the adoption pattern of these systems across end users. The client was also interested in understanding the factors likely to affect market growth during the forecast period. The client wanted to take a decision – whether launching 6mV single-photon systems in these countries would be fruitful or not.
MnM Approach
MnM started by identifying key players of 6mV single-photon radiotherapy systems that were changing the revenue mix of our client’s clients in end-use industries such as radiotherapy centers and cancer specialty hospitals across South America, Eastern Europe, Asia, and Africa. MnM further carried out an end user perception analysis by interviewing a host of potential end users to understand the adoption pattern & growth perceptive of 6mV systems, key players of the market, preference of patients for these systems for treatment, unmet needs from the end user perspective, availability of alternatives in the market, and limitations faced by users of 6mv single-photon radiotherapy systems.
This helped the client to assess the market potential as well as the high impact of these systems in developing countries. Further, MnM also helped the client build an understanding of the competitive landscape in this market. This helped them devise a differentiated product offering and forge suitable alliances to help them win in these developing markets.
Revenue Impact (RI)
MnM helped the client to expand into 6mV single-photon radiotherapy systems market resulting in an incremental revenue of USD 50 million by 2022
By type, the external beam radiotherapy segment is expected to grow at the highest rate during the forecast period
Based on type, the radiotherapy market is segmented into external beam radiotherapy, internal beam radiotherapy/brachytherapy, and systemic radiotherapy. The external beam radiotherapy segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment can primarily be attributed to the reduced risk of radiation exposure in external beam radiotherapy and the increased precision and accuracy of tumor targeting in this therapy.
By end user, the hospitals segment is expected to be the largest contributor to the radiotherapy market
Based on end user, the radiotherapy market has been segmented into hospitals and independent radiotherapy centers. The hospitals segment is expected to account for the largest share of the radiotherapy market in 2018 owing to the rising global prevalence of cancer, increasing installations of advanced radiotherapy equipment in developed as well as developing regions, increasing government initiatives aimed at equipping (or upgrading) hospitals with newer and advanced radiotherapy systems, and the increasing availability of funding for the adoption of advanced cancer treatment technologies.
Asia Pacific is expected to grow at the fastest rate in the radiotherapy market during the forecast period
The Asia Pacific is one of the major revenue-generating regions in the radiotherapy market. China, India, and Japan are the major countries responsible for the high growth of this regional market owing to factors such as the increasing per capita income, improving healthcare infrastructure, and supportive government activities in these emerging countries. Furthermore, the increasing geriatric population, the growing incidence of cancer, and the rising acceptance of radiotherapy procedures and devices are also driving the growth of this regional market.
Market Dynamics
Market growth is largely driven by factors such as technological advancements, the rising prevalence of cancer, the increasing number of conferences and symposia focusing on spreading awareness about the benefits of radiotherapy, and the growing use of particle therapy for cancer treatment. The emerging markets, growing government and private investments to meet the increasing demand for cancer treatment, and the improving reimbursement scenario are expected to present a wide range of growth opportunities for market players.
Driver: Technological advancement
Over the last decade, the radiotherapy devices market has seen significant technological advancements. These advancements have helped in the development of more effective, low-cost, and easy-to-use radiotherapy products with improved and precise radiation dose delivery to offer increased efficiency in targeting tumors. The advancement from 2D to 3D conformal radiotherapy with real-time imaging has enabled high conformity of radiation to the target (with minimal exposure to normal tissue) and dose escalation with improved tumor control. Products that provide these benefits are expected to have a very high growth potential in a short time span, especially in mature markets where the adoption rate of technologically advanced products is high.
Considering these factors, several key market players are continuously focusing on the development, approval, and launch of technologically advanced products. Some of the major developments in this regard have been mentioned below:
- In 2018, Varian Medical Systems (US) launched the ProBeam 360 single-room proton therapy system. This new particle accelerator has a 360-degree rotating gantry and high-definition pencil-beam scanning technology capable of providing efficient Intensity Modulated Proton Therapy (IMPT).
- In 2018, Hitachi Ltd. (Japan) received FDA 510(k) approval for the commercialization of its Real Time Image Gating System for Proton Beam Therapy Systems (RGPT). This will allow patients to be treated with cutting-edge motion management along with the company’s advanced Spot Scanning irradiation technology.
- In 2018, the Elekta Unity magnetic resonance radiation therapy (MR/RT) system received CE mark for commercial use across Europe. This integrated product will allow the delivery of the radiation doses along with the simultaneous visualization of the tumor and surrounding healthy tissue with high-quality MR images.
- In 2017, Varian Medical Systems (US) introduced the new Halcyon treatment system designed with improved rapid image-guided IMRT, RapidArc radiotherapy, and a patented dual-layer multi-leaf collimator (MLC).
- In 2016, Sumitomo Heavy Industries (Japan) received FDA approval for the use of the pencil-beam scanning technology in its proton therapy system.
Such technological advancements focus on improving the functionality of radiotherapy delivery systems and expanding their application areas. Considering these benefits, the adoption of radiotherapy is increasing in various hospitals and independent radiotherapy centers. Some of the related developments have been mentioned below:
- In 2018, Elekta (Sweden) signed a contract with Instituto Mexicano del Seguro Social (IMSS, Mexico) to supply five linear accelerators (including Elekta Synergy and Elekta Infinity systems) to IMSS.
- In 2018, Elekta (Sweden) announced the acquisition of 10 Flexitron afterloading platforms by the National Health Service (NHS) Supply Chain to provide safe brachytherapy treatment across the UK.
- In 2018, the Children’s Cancer Hospital Foundation Egypt (CCHF) signed a contract with IBA (Belgium) to install a Proteus ONE compact proton therapy solution at Hospital 57357 (CCHE) in Cairo.
- In 2017, the government of the Wallonia region (Belgium), along with four leading Belgian universities [Universities of Brussels (ULB), Liège (Ulg), Mons (UMons), and Namur (UNamur)], installed the Proteus ONE solution by IBA (Belgium).
- In 2016, Accuray (US) announced the installation of the radiation therapy technology in centers in Qatar, Latvia, and Bulgaria.
- In 2016, the Netherlands Cancer Institute installed the high-field (1.5 Tesla) MR-guided linear accelerator (MR-linac) system.
- In 2015, the Fundacion Arturo Lopez Perez (FALP) Cancer Institute in Santiago (Chile) installed the first CyberKnife M6 and TomoTherapy systems in Chile.
The growing adoption of these systems in multiple applications and settings is one of the major factors driving the growth of the radiotherapy market.
Restraint: Shortage of trained personnel
The radiotherapy market is witnessing continuous technological innovations and advancements aimed towards making the devices and techniques more accurate and specific. However, radiotherapy is a clinical modality wherein high standards can only be achieved and maintained by full-time specialists. The implementation of advanced radiotherapy is thus expected to be hampered by the shortage of trained personnel and the lack of technical expertise.
A large number of cancer patients miss out on effective and advanced radiotherapy procedures due to the shortage of skilled and trained personnel. The severity of this situation is expected to grow with an expected 20% increase in the number of cancer patients by 2020. Also, the impact of this factor is higher in developing and underdeveloped countries. It is estimated that by 2020, the demand for radiotherapy units will increase to at least 9,100 treatment units in 84 countries classified as LMICs (low- and middle-income countries), accompanied by the need for at least 12,000 radiation oncologists (Source: Scientific Research Publishing, Inc.).
According to the American College of Radiology 2015 Commission on Human Resources Workforce survey findings, the number of general radiologists has fallen by almost half in the last two years in the US, now accounting for 12.8% of all radiologists. Similarly, according to the Clinical Radiology UK Workforce Census 2016 Report, the UK has 7.5 radiologists/100,000 patients—the third lowest among European countries. The significant gap between the demand and supply of trained radiation oncologists and the lack of trained radiographers is expected to hamper the adoption of radiotherapy products across the globe in the coming years.
Scope of the Report
|
Report Metric |
Details |
|
Market Size Available for Years |
2016–2023 |
|
Base Year Considered |
2017 |
|
Forecast Period |
2018–2023 |
|
Forecast Units |
Value (USD) |
|
Segments Covered |
Type, Product Type, Application, End User, and Region |
|
Geographies Covered |
North America (US & Canada), Europe (Germany, France, UK, and RoE), APAC (Japan, China, India, and RoAPAC), and the RoW |
|
Companies Covered |
Varian Medical Systems, Inc. (US), Elekta (Sweden), Accuray Incorporated (US), Ion Beam Applications SA (Belgium), ViewRay, Inc. (US), IsoRay Medical, Inc. (US), Hitachi Ltd. (Japan), Panacea Medical Technologies Pvt. Ltd. (India), Provision Healthcare (US), and Mevion Medical Systems, Inc. (US). Major 15 players covered. |
This research report categorizes the radiotherapy market based on type, product type, application, end user, and region.
Radiotherapy Market, by Product Type
- External Beam Radiotherapy Products
- Linear Accelerators (LINAC)
- Conventional LINAC
- Stereotactic Advanced Electron/Cobalt-60 LINAC
- CyberKnife
- Gamma Knife
- TomoTherapy
- Particle Therapy Systems
- Cyclotrons
- Synchrotrons
- Synchrocyclotrons
- Conventional Cobalt-60 Teletherapy Units
- Internal Beam Radiotherapy/Brachytherapy Products
- Seeds
- Applicators
- Afterloaders
- Electronic Brachytherapy Products
- Systemic Radiotherapy
- Iobenguane-131
- Samarium-153
- Rhenium-186
- Other Systemic Radiotherapy Products (yttrium-90, radium-223, phosphorous-32, and radio-labelled antibodies, among others)
- Linear Accelerators (LINAC)
Radiotherapy Market, by Type
- External Beam Radiotherapy
- Image-guided Radiotherapy (IGRT)
- Intensity-modulated Radiotherapy (IMRT)
- TomoTherapy
- Volumetric Modulated Arc Therapy (VMAT)
- Stereotactic Therapy
- 3D Conformal Radiotherapy (3D-CRT)
- Particle Beam Therapy (Heavy-ion and Proton Therapy)
- Internal Beam Radiotherapy/Brachytherapy
- Low-dose-rate (LDR) Brachytherapy
- High-dose-rate (HDR) Brachytherapy
- Pulsed-dose-rate (PDR) Brachytherapy
- Systemic Radiotherapy
- Intravenous Radiotherapy
- Oral Radiotherapy
- Instillation Radiotherapy
Radiotherapy Market, by Application
- External Beam Radiotherapy
- Prostate Cancer
- Breast Cancer
- Lung Cancer
- Head & Neck Cancer
- Colorectal Cancer
- Others cancers (spine cancer, brain cancer, and pediatric cancer, among others)
- Internal Beam Radiotherapy/Brachytherapy
- Prostate Cancer
- Gynecological Cancer
- Breast Cancer
- Cervical Cancer
- Penile Cancer
- Other cancers (lung cancer and head and neck cancer, among others)
Radiotherapy Market, by End User
- Hospitals
- Independent Radiotherapy Centers
Radiotherapy Market, by Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- RoE
- Asia Pacific
- Japan
- China
- India
- RoAPAC
- Rest of the World
Key Market Players
Varian Medical Systems, Inc. (US), Elekta AB (Sweden), and Accuray Incorporated (US) dominated the radiotherapy market. Other players in this market include Ion Beam Applications SA (Belgium), ViewRay, Inc. (US), IsoRay Medical, Inc. (US), Hitachi Ltd. (Japan), Panacea Medical Technologies Pvt. Ltd. (India), Provision Healthcare (US), and Mevion Medical Systems, Inc. (US),
Varian Medical Systems (US) is one of the leading players in the global radiotherapy market. Its broad portfolio of radiotherapy systems and brachytherapy products is the key factor accounting for its large share in this market. The company has adopted both organic and inorganic growth strategies such as agreements, partnerships, collaborations, product launches, and contracts to maintain its top position in the field of radiotherapy. The company is also focused on providing training and conducting workshops to increase the adoption of its products.
Recent Developments
- In 2017, Mitsubishi Electric signed an agreement to transfer its particle therapy systems business to Hitachi and integrate into one entity.
- In 2017, Varian Medical Systems opened its new facility in Jundiai, Brazil. This expansion is aimed to increase access to advanced radiotherapy treatment in the country.
- In 2016, Varian Medical Systems launched an innovative treatment platform—Halcyon Treatment System. The product simplifies treatment delivery with high-quality plans delivered at significantly increased speeds.
Key Questions Addressed by the Report:
- What are the growth opportunities related to the adoption of radiotherapy across major regions in the future?
- Emerging countries have immense opportunities for the growth and adoption of radiotherapy. Will this scenario continue in the next five years?
- Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
- What are the various cancer types wherein radiotherapy finds a high adoption rate?
- What are the new trends and advancements in the radiotherapy market?
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 21)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders
2 Research Methodology (Page No. - 24)
2.1 Research Data
Figure 1 Radiotherapy Market: Research Methodology Steps
Figure 2 Research Design
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
Figure 3 Breakdown of Primaries: Global Market
Figure 4 Research Methodology: Hypothesis Building
2.2 Market Size Estimation
2.2.1 Product-Based Market Estimation
Figure 5 Radiotherapy Market Size Estimation: Bottom-Up Approach
Figure 6 Market Size Estimation: Top-Down Approach
2.2.2 Primary Research Validation
2.3 Market Breakdown and Data Triangulation
Figure 7 Data Triangulation Methodology
2.4 Research Limitations and Assumptions
2.4.1 Limitations
2.4.2 Assumptions
3 Executive Summary (Page No. - 35)
Figure 8 Radiotherapy Market, By Type, 2018 (USD Million)
Figure 9 External Beam Market, By Product Type, 2018 vs 2023 (USD Million)
Figure 10 Internal Beam Market, By Product Type, 2018 vs 2023 (USD Million)
Figure 11 External Beam Radiotherapy Market Share, By Application, 2018 vs 2023
Figure 12 Radiotherapy Market, By End User, 2018 vs 2023 (USD Million)
Figure 13 Radiotherapy Market: Geographical Snapshot
4 Premium Insights (Page No. - 40)
4.1 Radiotherapy Market Overview
Figure 14 Rising Cancer Prevalence Across the Globe is Driving Growth in the Radiotherapy Market
4.2 Europe: External Radiotherapy Market, By Type, 2018
Figure 15 Image-Guided Radiotherapy to Dominate the External Beam Radiotherapy Market in Europe in 2018
4.3 Internal Beam Radiotherapy/Brachytherapy Market, By Product Type
Figure 16 Afterloaders to Register the Highest CAGR in the Market During the Forecast Period
4.4 External Beam Radiotherapy Market, By Application
Figure 17 Others Cancer Application Segment to Grow at the Fastest Rate in the External Beam Market During the Forecast Period
4.5 Regional Analysis: Radiotherapy Market, By End User
Figure 18 North America to Dominate the Radiotherapy End User Market in 2018
4.6 Radiotherapy Market, By Country
Figure 19 China to Register the Highest CAGR During the Forecast Period (2018–2023)
5 Market Overview (Page No. - 46)
5.1 Introduction
5.2 Market Dynamics
Figure 20 Radiotherapy Market: Drivers, Restraints, Opportunities, and Challenges
5.2.1 Drivers
5.2.1.1 Technological Advancements
5.2.1.2 Rising Prevalence of Cancer
Figure 21 Incidence of Cancer, By Region, 2012–2020 (Thousand)
5.2.1.3 Increasing Number of Conferences and Symposia Focusing on Spreading Awareness About the Benefits of Radiotherapy
5.2.1.4 Growing Use of Particle Therapy for Cancer Treatment
5.2.2 Restraints
5.2.2.1 Lack of Adequate Healthcare Infrastructure
5.2.2.2 Shortage of Trained Personnel
5.2.2.3 Affordability and Accessibility of Treatment
5.2.2.4 Complex Nature of Radiotherapy
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Growing Government and Private Investments to Meet the Increasing Demand for Cancer Treatment
5.2.3.3 Improving Reimbursement Scenario
Table 1 National Average Medicare Reimbursement: Outpatient Prospective Payment System (OPPS) Estimated Per Course
5.2.4 Challenges
5.2.4.1 Difficulties in Visualizing Tumors During Radiotherapy Procedures
5.2.4.2 Risk of Radiation Exposure
5.3 Industry Trends
5.3.1 Growing Adoption of Pencil-Beam Scanning
5.3.2 Growing Number of Collaborations and Acquisitions
6 Radiotherapy Market, By Product Type (Page No. - 58)
6.1 Introduction
Table 2 Radiotherapy Market, By Product Type, 2016–2023 (USD Million)
6.2 External Beam Radiotherapy
Figure 22 Particle Therapy Systems to Register Highest Growth in the External Beam Radiotherapy Market During the Forecast Period
Table 3 External Beam Market, By Product Type, 2016–2023 (USD Million)
Table 4 External Beam Market, By Region, 2016–2023 (USD Million)
6.2.1 Linear Accelerators (LINAC)
Table 5 External Beam Market for Linear Accelerators, By Type, 2016–2023 (USD Million)
Table 6 External Beam Market for Linear Accelerators, By Region, 2016–2023 (USD Million)
6.2.1.1 Conventional Linear Accelerators
Table 7 Conventional Linear Accelerators Market, By Region, 2016–2023 (USD Million)
6.2.1.1.1 Lower Equipment and Maintenance Cost Will Drive the Market for Conventional LINACs
6.2.1.2 Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators
6.2.1.2.1 Automation and Real-Time Tracking Features have Ensured Demand for Stereotactic Advanced LINAC
Table 8 Stereotactic Advanced Electron/Cobalt-60 LINAC Market, By Product Type, 2016–2023 (USD Million)
Table 9 Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators Market, By Region, 2016–2023 (USD Million)
6.2.1.2.2 Gamma Knife
6.2.1.2.2.1 The Gamma Knife System is Considered A Gold Standard for Brain Tumor Treatment
Table 9 Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators Market, By Region, 2016–2023 (USD Million)
6.2.1.2.3 Cyberknife
6.2.1.2.3.1 Cyberknife Offers A Precise Radiation Delivery Method With Specialized Tracking and Robotic Correction Capabilities
Table 11 Cyberknife Market, By Region, 2016–2023 (USD Million)
6.2.1.2.4 Tomotherapy
6.2.1.2.4.1 360-Degree (Helical) Radiation Treatment With Tomotherapy is Adding Growth Opportunities to This Segment
Table 12 Tomotherapy Market, By Region, 2016–2023 (USD Million)
6.2.2 Particle Therapy Systems
Table 13 External Beam Radiotherapy Market for Particle Therapy Systems, By Product Type, 2016–2023 (USD Million)
Table 14 External Beam Market for Particle Therapy Systems, By Region, 2016–2023 (USD Million)
6.2.2.1 Cyclotrons
6.2.2.1.1 Leading Players in the Particle Therapy Market Mainly Manufacture Cyclotrons
Table 15 Particle Therapy Systems Market for Cyclotrons, By Region, 2016–2023 (USD Million)
6.2.2.2 Synchrotrons
6.2.2.2.1 Increasing Investment for the Development of Synchrotron Facilities are Contributing to Market Growth
Table 16 Particle Therapy Systems Market for Synchrotrons, By Region, 2016–2023 (USD Million)
6.2.2.3 Synchrocyclotrons
6.2.2.3.1 High Space Requirements of Synchrocyclotrons are Limiting Its Widespread Adoption
Table 17 Particle Therapy Systems Market for Synchrocyclotrons, By Region, 2016–2023 (USD Million)
6.2.3 Conventional Cobalt-60 Teletherapy Units
6.2.3.1 High Cost and Risk of Radiation Exposure With Cobalt-60 Radioisotopes have Hindered the Growth of This Segment
Table 18 External Beam Market for Conventional Cobalt-60 Teletherapy Units, By Region, 2016–2023 (USD Million)
6.3 Internal Beam Radiotherapy/Brachytherapy
Figure 23 Seeds to Dominate Internal Beam Radiotherapy Market During the Forecast Period
Table 19 Internal Beam Radiotherapy/Brachytherapy Market, By Product Type, 2016–2023 (USD Million)
Table 20 Internal Beam Radiotherapy/Brachytherapy Market, By Region, 2016–2023 (USD Million)
6.3.1 Seeds
6.3.1.1 Adverse Side-Effects Associated With Seeds Limit Their Adoption
Table 21 Internal Beam Radiotherapy/Brachytherapy Market for Seeds, By Region, 2016–2023 (USD Million)
6.3.2 Applicators
6.3.2.1 Manual Applicators Pose A High Risk of Radiation Exposure to the Patients and Staff
Table 22 Internal Beam Radiotherapy/Brachytherapy Market for Applicators, By Region, 2016–2023 (USD Million)
6.3.3 Afterloaders
6.3.3.1 Modern Afterloaders Offer Proper Positioning and Better Control of Isotopes Inside the Patient Body
Table 23 Internal Beam Radiotherapy/Brachytherapy Market for Afterloaders, By Region, 2016–2023 (USD Million)
6.3.4 Electronic Brachytherapy Products
6.3.4.1 Electronic Brachytherapy Requires Low Amount of Shielding Than Alternatives
Table 24 Internal Beam Radiotherapy/Brachytherapy Market for Electronic Brachytherapy Products, By Region, 2016–2023 (USD Million)
6.4 Systemic Radiotherapy
6.4.1 Iobenguane (I-131)
6.4.1.1 Increasing Incidence of Thyroid Cancer is Driving the Growth of This Segment
6.4.2 Samarium-153
6.4.2.1 Samarium-153 has Wide Applications for Bone Metastasis
6.4.3 Rhenium-186
6.4.3.1 Lack of Insurance Coverage With the Use of Rhenium-186 Restricting Its Growth
6.4.4 Other Systemic Radiotherapy Products
7 Radiotherapy Market, By Type (Page No. - 80)
7.1 Introduction
Table 25 Radiotherapy Market, By Type, 2016–2023 (USD Million)
7.2 External Beam Radiotherapy
Figure 24 Image-Guided Radiotherapy Segment to Account for the Largest Share of the External Beam Market in 2018
Table 26 External Beam Market, By Type, 2016–2023 (USD Million)
Table 27 External Beam Market, By Region, 2016–2023 (USD Million)
7.2.1 Image-Guided Radiotherapy (IMRT)
7.2.1.1 Image-Guided Radiotherapy is Widely Used to the Treatment of Deep-Seated Tumors
Table 28 Image-Guided Market, By Region, 2016–2023 (USD Million)
7.2.2 3D Conformal Radiotherapy (3D CRT)
7.2.2.1 Multiple Beams With 3D-CRT Allow Precise Radiation Conforming to the Tumor Size and Shape
Table 29 3D Conformal Market, By Region, 2016–2023 (USD Million)
7.2.3 Intensity-Modulated Radiotherapy (IMRT)
Table 30 Intensity-Modulated Market, By Type, 2016–2023 (USD Million)
Table 31 Intensity-Modulated Market, By Region, 2016–2023 (USD Million)
7.2.3.1 Volumetric Arc Therapy (VMAT)
7.2.3.1.1 Advancements in the VMAT Technology Driving Its Widespread Adoption
Table 32 Volumetric Arc Therapy Market, By Region, 2016–2023 (USD Million)
7.2.3.2 Tomotherapy
7.2.3.2.1 Minimal Exposure to Normal Tissues – A Major Advantage of Tomotherapy
Table 33 Tomotherapy Market, By Region, 2016–2023 (USD Million)
7.2.4 Stereotactic Therapy
7.2.4.1 Stereotactic Therapy Offers A Minimally Invasive Alternative to Ablation Surgeries
Table 34 Stereotactic Therapy Market, By Region, 2016–2023 (USD Million)
7.2.5 Particle Therapy (Heavy-Ion and Proton Therapy)
7.2.5.1 Particle Therapy is Increasingly Being Adopted as A Primary Mode of Treatment for Various Cancer Types
Figure 25 Number of Particle Therapy Facilities Present (As of October 2018) & Under Construction Across the Globe
Table 35 Particle Therapy Market, By Region, 2016–2023 (USD Million)
7.3 Internal Beam Radiotherapy
Figure 26 High-Dose-Rate Brachytherapy Segment is Expected to Account for the Largest Share of the Internal Beam Market in 2018
Table 36 Internal Beam Radiotherapy/Brachytherapy Market, By Type, 2016–2023 (USD Million)
Table 37 Internal Beam Radiotherapy/Brachytherapy Market, By Region, 2016–2023 (USD Million)
7.3.1 Low-Dose-Rate (LDR) Brachytherapy
7.3.1.1 Lower Risk of Radiation Exposure to the Surrounding Tissues With LDR Supporting Market Growth
Table 38 Low-Dose-Rate Brachytherapy Market, By Region, 2016–2023 (USD Million)
7.3.2 High-Dose-Rate (HDR) Brachytherapy
7.3.2.1 Better Patient Care With HDR is Driving Its Widespread Adoption
Table 39 High-Dose-Rate Brachytherapy Market, By Region, 2016–2023 (USD Million)
7.3.3 Pulsed-Dose-Rate (PDR) Brachytherapy
7.3.3.1 Pulsed-Dose Rate Brachytherapy Combines the Advantages of HDR and LDR Brachytherapy
Table 40 Pulsed-Dose-Rate Brachytherapy Market, By Region, 2016–2023 (USD Million)
7.4 Systemic Radiotherapy
7.4.1 Intravenous Radiotherapy
7.4.1.1 Intravenous Route of Brachytherapy Results in Maximum Bioavailability
7.4.2 Oral Radiotherapy
7.4.2.1 Longer Distribution Time Associated With the Oral Mode of Radiation Delivery Limiting Its Demand
7.4.3 Instillation Radiotherapy
7.4.3.1 Lesser Localization With Instillation Brachytherapy is Limiting Its Widespread Adoption
8 Radiotherapy Market, By Application (Page No. - 97)
8.1 Introduction
Table 41 Radiotherapy Applications Market, By Type, 2016-2023 (USD Million)
8.2 External Beam Radiation Therapy
Figure 27 Prostate Cancer to Dominate the External Beam Radiotherapy Applications Market During the Forecast Period
Table 42 External Beam Radiotherapy Applications Market, By Type, 2016-2023 (USD Million)
8.2.1 Prostate Cancer
8.2.1.1 High Incidence of Prostate Cancer Will Drive the Demand for Ebrt
Table 43 External Beam Radiotherapy Applications Market for Prostate Cancer, By Region, 2016-2023 (USD Million)
8.2.2 Breast Cancer
8.2.2.1 Adoption of Advanced Ebrt Systems and Increasing Research Will Drive Market Growth
Table 44 External Beam Radiotherapy Applications Market for Breast Cancer, By Region, 2016-2023 (USD Million)
8.2.3 Lung Cancer
8.2.3.1 Radiotherapy Can Be Used as Solo Or Combination Therapy for Lung Cancer
Table 45 External Beam Radiotherapy Applications Market for Lung Cancer, By Region, 2016-2023 (USD Million)
8.2.4 Head and Neck Cancer
8.2.4.1 Benefits of External Radiotherapy Will Support Its Use in Head and Neck Cancer Treatment
Table 46 External Beam Radiotherapy Applications Market for Head and Neck Cancer, By Region, 2016-2023 (USD Million)
8.2.5 Colorectal Cancer
8.2.5.1 Availability of Alternative Therapeutic Options Limits the Growth of This Segment
Table 47 External Beam Radiotherapy Applications Market for Colorectal Cancer, By Region, 2016-2023 (USD Million)
8.2.6 Other Cancers
Table 48 External Beam Radiotherapy Applications Market for Other Cancers, By Region, 2016-2023 (USD Million)
8.3 Internal Beam Radiotherapy/Brachytherapy
Figure 28 Breast Cancer to Register Highest Growth in Internal Beam Radiotherapy/Brachytherapy Applications Market
Table 49 Internal Beam Radiotherapy/Brachytherapy Applications Market, By Type, 2016-2023 (USD Million)
8.3.1 Prostate Cancer
8.3.1.1 Rapidity and Precision of Brachytherapy in Prostate Cancer Treatment have Driven Market Growth
Table 50 Internal Beam Radiotherapy/Brachytherapy Applications Market for Prostate Cancer, By Region, 2016-2023 (USD Million)
8.3.2 Gynecological Cancer
8.3.2.1 Availability of Alternatives Hinders the Adoption of Brachytherapy in Gynecological Cancer Treatment
Table 51 Internal Beam Radiotherapy/Brachytherapy Applications Market for Gynecological Cancer, By Region, 2016-2023 (USD Million)
8.3.3 Breast Cancer
8.3.3.1 Precision and Rapid Treatment Times are Driving the Use of Brachytherapy in Breast Cancer Applications
Table 52 Internal Beam Radiotherapy/Brachytherapy Applications Market for Breast Cancer, By Region, 2016-2023 (USD Million)
8.3.4 Cervical Cancer
8.3.4.1 A Combination of Brachytherapy and Chemotherapy is Typically Used for Cervical Cancer Treatment
Table 53 Internal Beam Radiotherapy/Brachytherapy Applications Market for Cervical Cancer, By Region, 2016-2023 (USD Million)
8.3.5 Penile Cancer
8.3.5.1 Advantages of Brachytherapy in Penile Cancer Treatment have Driven Its Adoption
Table 54 Internal Beam Radiotherapy/Brachytherapy Applications Market for Penile Cancer, By Region, 2016-2023 (USD Million)
8.3.6 Other Cancers
Table 55 Internal Beam Radiotherapy/Brachytherapy Applications Market for Other Cancers, By Region, 2016-2023 (USD Million)
9 Radiotherapy Market, By End User (Page No. - 114)
9.1 Introduction
Figure 29 Hospitals Segment to Grow at the Highest CAGR During the Forecast Period
Table 56 Radiotherapy Market, By End User, 2016–2023 (USD Million)
9.1.1 Hospitals
9.1.1.1 Increasing Number of Small-Footprint Advanced Radiotherapy Products Promoting Their Adoption in Hospitals
Table 57 Radiotherapy Market for Hospitals, By Region, 2016–2023 (USD Million)
9.1.2 Independent Radiotherapy Centers
9.1.2.1 Rising Consolidation of Healthcare Networks is Challenging the Growth of Freestanding Radiotherapy Centers
Table 58 Radiotherapy Market for Independent Radiotherapy Centers, By Region, 2016–2023 (USD Million)
10 Radiotherapy Market, By Region (Page No. - 119)
10.1 Introduction
Table 59 Radiotherapy Market, By Region, 2016–2023 (USD Million)
10.2 North America
Figure 30 North America: Radiotherapy Market Snapshot
Table 60 North America: Market, By Country, 2016–2023 (USD Million)
Table 61 North America: Market, By Type, 2016–2023 (USD Million)
Table 62 North America: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 63 North America: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 64 North America: Stereotactic Advanced Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 65 North America: Particle Therapy Systems Market, By Type, 2016–2023 (USD Million)
Table 66 North America: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 67 North America: External Beam Market, By Type, 2016–2023 (USD Million)
Table 68 North America: Intensity-Modulated Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 69 North America: Internal Beam Radiotherapy/Brachytherapy Market, By Type, 2016–2023 (USD Million)
Table 70 North America: External Beam Radiotherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 71 North America: Internal Beam Radiotherapy/Brachytherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 72 North America: Radiotherapy Market, By End User, 2016–2023 (USD Million)
10.2.1 US
10.2.1.1 Growing Government Initiatives Boosting the Adoption of Radiotherapy in the Us
Table 73 US: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 74 US: External Beam Market, By Product, 2016–2023 (USD Million)
Table 75 US: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 76 US: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
10.2.2 Canada
10.2.2.1 Rising Cancer Incidence Driving the Demand for Radiotherapy in Canada
Table 77 Canada: Market, By Type, 2016–2023 (USD Million)
Table 78 Canada: External Beam Market, By Product, 2016–2023 (USD Million)
Table 79 Canada: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 80 Canada: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
10.3 Europe
Figure 31 Europe: Market Snapshot
Table 81 Europe: Radiotherapy Market, By Country, 2016–2023 (USD Million)
Table 82 Europe: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 83 Europe: External Beam Market, By Product, 2016–2023 (USD Million)
Table 84 Europe: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 85 Europe: Stereotactic Advanced Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 86 Europe: Particle Therapy Systems Market, By Type, 2016–2023 (USD Million)
Table 87 Europe: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 88 Europe: External Beam Market, By Type, 2016–2023 (USD Million)
Table 89 Europe: External Beam Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 90 Europe: Internal Beam Radiotherapy/Brachytherapy Market, By Type, 2016–2023 (USD Million)
Table 91 Europe: External Beam Radiotherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 92 Europe: Internal Beam Radiotherapy/Brachytherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 93 Europe: Radiotherapy Market, By End User, 2016–2023 (USD Million)
10.3.1 Germany
10.3.1.1 Increasing Awareness of Novel and Advanced Radiotherapy Products A Key Factor Contributing to Market Growth
Table 94 Germany: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 95 Germany: External Beam Market, By Product, 2016–2023 (USD Million)
Table 96 Germany: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 97 Germany: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
10.3.2 France
10.3.2.1 Growing Government Initiatives Boosting the Adoption of Radiotherapy in France
Table 98 France: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 99 France: External Beam Market, By Product, 2016–2023 (USD Million)
Table 100 France: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 101 France: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
10.3.3 UK
10.3.3.1 Leading Market Players Focusing on Expanding Their Product Offerings in the Uk
Table 102 UK: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 103 UK: External Beam Market, By Product, 2016–2023 (USD Million)
Table 104 UK: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 105 UK: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
10.3.4 Rest of Europe
Table 106 Rest of Europe: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 107 Rest of Europe: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 108 Rest of Europe: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 109 Rest of Europe: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
10.4 Asia Pacific
Figure 32 Asia Pacific: Market Snapshot
Table 110 Asia Pacific: Radiotherapy Market, By Country, 2016–2023 (USD Million)
Table 111 Asia Pacific: Market, By Type, 2016–2023 (USD Million)
Table 112 Asia Pacific: External Beam Market, By Product, 2016–2023 (USD Million)
Table 113 Asia Pacific: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 114 Asia Pacific: Stereotactic Advanced Linear Accelerators Market, By Product, 2016–2023 (USD Million)
Table 115 Asia Pacific: Particle Therapy Systems Market, By Product, 2016–2023 (USD Million)
Table 116 Asia Pacific: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 117 Asia Pacific: External Beam Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 118 APAC: Intensity-Modulated Market, By Type, 2016–2023 (USD Million)
Table 119 Asia Pacific: Internal Beam Radiotherapy/Brachytherapy Market, By Type, 2016–2023 (USD Million)
Table 120 Asia Pacific: External Beam Radiotherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 121 Asia Pacific: Internal Beam Radiotherapy/Brachytherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 122 Asia Pacific: Radiotherapy Market, By End User, 2016–2023 (USD Million)
10.4.1 China
10.4.1.1 Presence of A Large Number of Local Manufactures Supporting the Growth of the Radiotherapy Market in China
Table 123 China: Market, By Type, 2016–2023 (USD Million)
Table 124 China: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 125 China: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 126 China: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
10.4.2 Japan
10.4.2.1 Rising Prevalence of Cancer is Driving the Adoption of Radiotherapy in Japan
Table 127 Japan: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 128 Japan: External Beam Market, By Product, 2016–2023 (USD Million)
Table 129 Japan: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 130 Japan: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
10.4.3 India
10.4.3.1 Shortage of Skilled Radiotherapy Professionals in India is Restraining Market Growth
Table 131 India: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 132 India: External Beam Market, By Product, 2016–2023 (USD Million)
Table 133 India: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 134 India: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
10.4.4 Rest of Asia Pacific
Table 135 RoAPAC: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 136 RoAPAC: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 137 RoAPAC: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 138 RoAPAC: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
10.5 Rest of the World
Figure 33 RoW: Radiotherapy Market Snapshot
Table 139 RoW: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 140 RoW: External Beam Market, By Product, 2016–2023 (USD Million)
Table 141 RoW: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 142 RoW: Stereotactic Advanced Linear Accelerators Market, By Product, 2016–2023 (USD Million)
Table 143 RoW: Particle Therapy Systems Market, By Product, 2016–2023 (USD Million)
Table 144 RoW: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 145 RoW: External Beam Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 146 RoW: Intensity-Modulated Market, By Type, 2016–2023 (USD Million)
Table 147 RoW: Internal Beam Radiotherapy/Brachytherapy Market, By Type, 2016–2023 (USD Million)
Table 148 RoW: External Beam Radiotherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 149 RoW: Internal Beam Radiotherapy/Brachytherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 150 RoW: Market, By End User, 2016–2023 (USD Million)
11 Competitive Landscape (Page No. - 173)
11.1 Introduction
Figure 34 Key Developments in the Radiotherapy Market Between 2015–2018
11.2 Market Share Analysis
Figure 35 Market Share, By Key Player, 2017
11.3 Competitive Scenario
11.3.1 Product Launches and Approvals
11.3.2 Acquisitions
11.3.3 Expansions
11.3.4 Partnerships, Agreements, and Collaborations
11.4 Vendor Dive Overview
11.5 Vendor Inclusion Criteria
11.6 Vendor Dive
11.6.1 Vanguards
11.6.2 Innovators
11.6.3 Dynamic Players
11.6.4 Emerging Companies
Figure 36 Competitive Leadership Mapping (Overall Market)
Figure 37 Competitive Leadership Mapping (SME/Start-Ups)
12 Company Profiles (Page No. - 182)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Accuray Incorporated
Figure 38 Accuray Incorporated: Company Snapshot (2018)
12.2 C. R. Bard, Inc.
Figure 39 C. R. Bard, Inc.: Company Snapshot (2016)
12.3 Elekta
Figure 40 Elekta Ab: Company Snapshot (2017)
12.4 Hitachi, LTD.
Figure 41 Hitachi: Company Snapshot (2017)
12.5 Iba (Ion Beam Applications Sa)
Figure 42 Ion Beam Applications Sa: Company Snapshot (2017)
12.6 Isoray Medical, Inc.
Figure 43 Isoray Medical, Inc.: Company Snapshot (2018)
12.7 Mevion Medical Systems, Inc.
12.8 Optivus Proton Therapy, Inc.
12.9 Panacea Medical Technologies Pvt. LTD.
12.10 P-Cure LTD.
12.11 Provision Healthcare, LLC.
12.12 Sumitomo Heavy Industries, LTD
Figure 44 Sumitomo Heavy Industries: Company Snapshot (2016)
12.13 Theragenics Corporation
12.14 Varian Medical Systems, Inc.
Figure 45 Varian Medical Systems, Inc.: Company Snapshot (2018)
12.15 Viewray Inc. Figure 46 Viewray, Inc.: Company Snapshot (2017)
*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.
13 Appendix (Page No. - 218)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Available Customizations
13.4 Related Reports
13.5 Author Details
List of Tables (150 Tables)
Table 1 National Average Medicare Reimbursement: Outpatient Prospective Payment System (OPPS) Estimated Per Course
Table 2 Radiotherapy Market, By Product Type, 2016–2023 (USD Million)
Table 3 External Beam Radiotherapy Market, By Product Type, 2016–2023 (USD Million)
Table 4 External Beam Radiotherapy Market, By Region, 2016–2023 (USD Million)
Table 5 External Beam Radiotherapy Market for Linear Accelerators, By Type, 2016–2023 (USD Million)
Table 6 External Beam Radiotherapy Market for Linear Accelerators, By Region, 2016–2023 (USD Million)
Table 7 Conventional Linear Accelerators (LINAC) Market, By Region, 2016–2023 (USD Million)
Table 8 Stereotactic Advanced Electron/Cobalt-60 LINAC Market, By Product Type, 2016–2023 (USD Million)
Table 9 Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators Market, By Region, 2016–2023 (USD Million)
Table 10 Gamma Knife Market, By Region, 2016–2023 (USD Million)
Table 11 Cyberknife Market, By Region, 2016–2023 (USD Million)
Table 12 Tomotherapy Market, By Region, 2016–2023 (USD Million)
Table 13 External Beam Radiotherapy Market for Particle Therapy Systems, By Product Type, 2016–2023 (USD Million)
Table 14 External Beam Radiotherapy Market for Particle Therapy Systems, By Region, 2016–2023 (USD Million)
Table 15 Particle Therapy Systems Market for Cyclotrons, By Region, 2016–2023 (USD Million)
Table 16 Particle Therapy Systems Market for Synchrotrons, By Region, 2016–2023 (USD Million)
Table 17 Particle Therapy Systems Market for Synchrocyclotrons, By Region, 2016–2023 (USD Million)
Table 18 External Beam Radiotherapy Market for Conventional Cobalt-60 Teletherapy Units, By Region, 2016–2023 (USD Million)
Table 19 Internal Beam Radiotherapy/Brachytherapy Market, By Product Type, 2016–2023 (USD Million)
Table 20 Internal Beam Radiotherapy/Brachytherapy Market, By Region, 2016–2023 (USD Million)
Table 21 Internal Beam Radiotherapy/Brachytherapy Market for Seeds, By Region, 2016–2023 (USD Million)
Table 22 Internal Beam Radiotherapy/Brachytherapy Market for Applicators, By Region, 2016–2023 (USD Million)
Table 23 Internal Beam Radiotherapy/Brachytherapy Market for Afterloaders, By Region, 2016–2023 (USD Million)
Table 24 Internal Beam Radiotherapy/Brachytherapy Market for Electronic Brachytherapy Products, By Region, 2016–2023 (USD Million)
Table 25 Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 26 External Beam Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 27 External Beam Radiotherapy Market, By Region, 2016–2023 (USD Million)
Table 28 Image-Guided Radiotherapy (IGRT) Market, By Region, 2016–2023 (USD Million)
Table 29 3D Conformal Radiotherapy (3D-CRT) Market, By Region, 2016–2023 (USD Million)
Table 30 Intensity-Modulated Radiotherapy (IMRT) Market, By Type, 2016–2023 (USD Million)
Table 31 Intensity-Modulated Radiotherapy (IMRT) Market, By Region, 2016–2023 (USD Million)
Table 32 Volumetric Arc Therapy (VMAT) Market, By Region, 2016–2023 (USD Million)
Table 33 Tomotherapy Market, By Region, 2016–2023 (USD Million)
Table 34 Stereotactic Therapy Market, By Region, 2016–2023 (USD Million)
Table 35 Particle Therapy Market, By Region, 2016–2023 (USD Million)
Table 36 Internal Beam Radiotherapy/Brachytherapy Market, By Type, 2016–2023 (USD Million)
Table 37 Internal Beam Radiotherapy/Brachytherapy Market, By Region, 2016–2023 (USD Million)
Table 38 Low-Dose-Rate (LDR) Brachytherapy Market, By Region, 2016–2023 (USD Million)
Table 39 High-Dose-Rate (HDR) Brachytherapy Market, By Region, 2016–2023 (USD Million)
Table 40 Pulsed-Dose-Rate (PDR) Brachytherapy Market, By Region, 2016–2023 (USD Million)
Table 41 Radiotherapy Applications Market, By Type, 2016-2023 (USD Million)
Table 42 External Beam Radiotherapy Applications Market, By Type, 2016-2023 (USD Million)
Table 43 External Beam Radiotherapy Applications Market for Prostate Cancer, By Region, 2016-2023 (USD Million)
Table 44 External Beam Radiotherapy Applications Market for Breast Cancer, By Region, 2016-2023 (USD Million)
Table 45 External Beam Radiotherapy Applications Market for Lung Cancer, By Region, 2016-2023 (USD Million)
Table 46 External Beam Radiotherapy Applications Market for Head and Neck Cancer, By Region, 2016-2023 (USD Million)
Table 47 External Beam Radiotherapy Applications Market for Colorectal Cancer, By Region, 2016-2023 (USD Million)
Table 48 External Beam Radiotherapy Applications Market for Other Cancers, By Region, 2016-2023 (USD Million)
Table 49 Internal Beam Radiotherapy/Brachytherapy Applications Market, By Type, 2016-2023 (USD Million)
Table 50 Internal Beam Radiotherapy/Brachytherapy Applications Market for Prostate Cancer, By Region, 2016-2023 (USD Million)
Table 51 Internal Beam Radiotherapy/Brachytherapy Applications Market for Gynecological Cancer, By Region, 2016-2023 (USD Million)
Table 52 Internal Beam Radiotherapy/Brachytherapy Applications Market for Breast Cancer, By Region, 2016-2023 (USD Million)
Table 53 Internal Beam Radiotherapy/Brachytherapy Applications Market for Cervical Cancer, By Region, 2016-2023 (USD Million)
Table 54 Internal Beam Radiotherapy/Brachytherapy Applications Market for Penile Cancer, By Region, 2016-2023 (USD Million)
Table 55 Internal Beam Radiotherapy/Brachytherapy Applications Market for Other Cancers, By Region, 2016-2023 (USD Million)
Table 56 Radiotherapy Market, By End User, 2016–2023 (USD Million)
Table 57 Radiotherapy Market for Hospitals, By Region, 2016–2023 (USD Million)
Table 58 Radiotherapy Market for Independent Radiotherapy Centers, By Region, 2016–2023 (USD Million)
Table 59 Radiotherapy Market, By Region, 2016–2023 (USD Million)
Table 60 North America: Radiotherapy Market, By Country, 2016–2023 (USD Million)
Table 61 North America: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 62 North America: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 63 North America: Linear Accelerators (LINAC) Market, By Type, 2016–2023 (USD Million)
Table 64 North America: Stereotactic Advanced Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 65 North America: Particle Therapy Systems Market, By Type, 2016–2023 (USD Million)
Table 66 North America: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 67 North America: External Beam Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 68 North America: Intensity-Modulated Radiotherapy (IMRT) Market, By Type, 2016–2023 (USD Million)
Table 69 North America: Internal Beam Radiotherapy/Brachytherapy Market, By Type, 2016–2023 (USD Million)
Table 70 North America: External Beam Radiotherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 71 North America: Internal Beam Radiotherapy/Brachytherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 72 North America: Radiotherapy Market, By End User, 2016–2023 (USD Million)
Table 73 US: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 74 US: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 75 US: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 76 US: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 77 Canada: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 78 Canada: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 79 Canada: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 80 Canada: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 81 Europe: Radiotherapy Market, By Country, 2016–2023 (USD Million)
Table 82 Europe: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 83 Europe: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 84 Europe: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 85 Europe: Stereotactic Advanced Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 86 Europe: Particle Therapy Systems Market, By Type, 2016–2023 (USD Million)
Table 87 Europe: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 88 Europe: External Beam Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 89 Europe: External Beam Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 90 Europe: Internal Beam Radiotherapy/Brachytherapy Market, By Type, 2016–2023 (USD Million)
Table 91 Europe: External Beam Radiotherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 92 Europe: Internal Beam Radiotherapy/Brachytherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 93 Europe: Radiotherapy Market, By End User, 2016–2023 (USD Million)
Table 94 Germany: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 95 Germany: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 96 Germany: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 97 Germany: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 98 France: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 99 France: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 100 France: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 101 France: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 102 UK: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 103 UK: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 104 UK: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 105 UK: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 106 Rest of Europe: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 107 Rest of Europe: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 108 Rest of Europe: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 109 Rest of Europe: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 110 Asia Pacific: Radiotherapy Market, By Country, 2016–2023 (USD Million)
Table 111 Asia Pacific: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 112 Asia Pacific: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 113 Asia Pacific: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 114 Asia Pacific: Stereotactic Advanced Linear Accelerators Market, By Product, 2016–2023 (USD Million)
Table 115 Asia Pacific: Particle Therapy Systems Market, By Product, 2016–2023 (USD Million)
Table 116 Asia Pacific: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 117 Asia Pacific: External Beam Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 118 APAC: Intensity-Modulated Radiotherapy (IMRT) Market, By Type, 2016–2023 (USD Million)
Table 119 Asia Pacific: Internal Beam Radiotherapy/Brachytherapy Market, By Type, 2016–2023 (USD Million)
Table 120 Asia Pacific: External Beam Radiotherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 121 Asia Pacific: Internal Beam Radiotherapy/Brachytherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 122 Asia Pacific: Radiotherapy Market, By End User, 2016–2023 (USD Million)
Table 123 China: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 124 China: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 125 China: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 126 China: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 127 Japan: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 128 Japan: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 129 Japan: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 130 Japan: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 131 India: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 132 India: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 133 India: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 134 India: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 135 RoAPAC: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 136 RoAPAC: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 137 RoAPAC: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 138 RoAPAC: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 139 RoW: Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 140 RoW: External Beam Radiotherapy Market, By Product, 2016–2023 (USD Million)
Table 141 RoW: Linear Accelerators Market, By Type, 2016–2023 (USD Million)
Table 142 RoW: Stereotactic Advanced Linear Accelerators Market, By Product, 2016–2023 (USD Million)
Table 143 RoW: Particle Therapy Systems Market, By Product, 2016–2023 (USD Million)
Table 144 RoW: Internal Beam Radiotherapy/Brachytherapy Market, By Product, 2016–2023 (USD Million)
Table 145 RoW: External Beam Radiotherapy Market, By Type, 2016–2023 (USD Million)
Table 146 RoW: Intensity-Modulated Radiotherapy (IMRT) Market, By Type, 2016–2023 (USD Million)
Table 147 RoW: Internal Beam Radiotherapy/Brachytherapy Market, By Type, 2016–2023 (USD Million)
Table 148 RoW: External Beam Radiotherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 149 RoW: Internal Beam Radiotherapy/Brachytherapy Applications Market, By Type, 2016–2023 (USD Million)
Table 150 RoW: Radiotherapy Market, By End User, 2016–2023 (USD Million)
List of Figures (46 Figures)
Figure 1 Radiotherapy Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primaries: Global Radiotherapy Market
Figure 4 Research Methodology: Hypothesis Building
Figure 5 Market Size Estimation: Bottom-Up Approach
Figure 6 Market Size Estimation: Top-Down Approach
Figure 7 Data Triangulation Methodology
Figure 8 Radiotherapy Market, By Type, 2018 (USD Million)
Figure 9 External Beam Radiotherapy Market, By Product Type, 2018 vs 2023 (USD Million)
Figure 10 Internal Beam Radiotherapy Market, By Product Type, 2018 vs 2023 (USD Million)
Figure 11 External Beam Radiotherapy Market Share, By Application, 2018 vs 2023
Figure 12 Radiotherapy Market, By End User, 2018 vs 2023 (USD Million)
Figure 13 Radiotherapy Market: Geographical Snapshot
Figure 14 Rising Cancer Prevalence Across the Globe is Driving Growth in the Radiotherapy Market
Figure 15 Image-Guided Radiotherapy (IMRT) to Dominate the External Beam Radiotherapy Market in Europe in 2018
Figure 16 Afterloaders to Register the Highest CAGR in the Market During the Forecast Period
Figure 17 Others Cancer Application Segment to Grow at the Fastest Rate in the External Beam Radiotherapy Market During the Forecast Period
Figure 18 North America to Dominate the Radiotherapy End User Market in 2018
Figure 19 China to Register the Highest CAGR During the Forecast Period (2018–2023)
Figure 20 Radiotherapy Market: Drivers, Restraints, Opportunities, and Challenges
Figure 21 Incidence of Cancer, By Region, 2012–2020 (Thousand)
Figure 22 Particle Therapy Systems to Register Highest Growth in the External Beam Radiotherapy Market During the Forecast Period
Figure 23 Seeds to Dominate Internal Beam Radiotherapy Market During the Forecast Period
Figure 24 Image-Guided Radiotherapy (IMRT) Segment to Account for the Largest Share of the External Beam Radiotherapy Market in 2018
Figure 25 Number of Particle Therapy Facilities Present (As of October 2018) & Under Construction Across the Globe
Figure 26 High-Dose-Rate (HDR) Brachytherapy Segment is Expected to Account for the Largest Share of the Internal Beam Radiotherapy Market in 2018
Figure 27 Prostate Cancer to Dominate the External Beam Radiotherapy Applications Market During the Forecast Period
Figure 28 Breast Cancer to Register Highest Growth in Internal Beam Radiotherapy/Brachytherapy Applications Market
Figure 29 Hospitals Segment to Grow at the Highest CAGR During the Forecast Period
Figure 30 North America: Radiotherapy Market Snapshot
Figure 31 Europe: Radiotherapy Market Snapshot
Figure 32 Asia Pacific: Radiotherapy Market Snapshot
Figure 33 RoW: Radiotherapy Market Snapshot
Figure 34 Key Developments in the Radiotherapy Market Between 2015–2018
Figure 35 Radiotherapy Market Share, By Key Player, 2017
Figure 36 Competitive Leadership Mapping (Overall Market)
Figure 37 Competitive Leadership Mapping (SME/Start-Ups)
Figure 38 Accuray Incorporated: Company Snapshot (2018)
Figure 39 C. R. Bard, Inc.: Company Snapshot (2016)
Figure 40 Elekta AB: Company Snapshot (2017)
Figure 41 Hitachi: Company Snapshot (2017)
Figure 42 Ion Beam Applications Sa: Company Snapshot (2017)
Figure 43 Isoray Medical, Inc.: Company Snapshot (2018)
Figure 44 Sumitomo Heavy Industries: Company Snapshot (2016)
Figure 45 Varian Medical Systems, Inc.: Company Snapshot (2018)
Figure 46 Viewray, Inc.: Company Snapshot (2017)
To get more details on this report, 
The study involved four major activities to estimate the current market size for radiotherapy. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for this study.
Primary Research
The radiotherapy market comprises several stakeholders such as radiotherapy product manufacturers, suppliers and distributors, healthcare service providers, and research institutes. The demand side of this market is characterized by the increasing awareness about minimally invasive cancer treatment options and the global rise in the prevalence of cancer. The supply side is characterized by advancements in technology. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is the breakdown of primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the radiotherapy market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets have been identified through extensive secondary research
- The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall market size using the market size estimation processes as explained above—the market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the radiotherapy industry.
Report Objectives
- To define, describe, and forecast the global radiotherapy market on the basis of type, product type, application, end user, and region
- To provide detailed information regarding the major factors (drivers, restraints, opportunities, challenges, and trends) influencing the growth of the global radiotherapy market
- To strategically analyze the micromarkets with respect to individual growth trends, future prospects, and contributions to the global radiotherapy market
- To analyze the opportunities in the global radiotherapy market for key stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa)
- To profile the key players in the global radiotherapy market and comprehensively analyze their market shares and core competencies
- To track and analyze competitive developments, such as product launches, agreements, partnerships, collaborations, and acquisitions in the global radiotherapy market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global radiotherapy market report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of the top five companies
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Radiotherapy Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Radiotherapy Market